Clinical trials
Overweight trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2013 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 13 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 20 |
| Active, not recruiting | 12 |
| Not yet recruiting | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 23 |
| Novo Nordisk A/S | 13 |
| Amgen | 8 |
| AstraZeneca | 8 |
| Pfizer | 3 |
| Hoffmann-La Roche | 2 |
| Hiroshima University | 1 |
| Sapporo Health Promotion Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 59 |
| Obesity | 55 |
| Diabetes Mellitus, Type 2 | 16 |
| Nutrition Disorders | 5 |
| Body Weight | 3 |
| Sleep Apnea, Obstructive | 3 |
| Diabetes Mellitus | 2 |
| Hypertension | 2 |
| Metabolic Diseases | 2 |
| Prediabetic State | 2 |
Trials
Showing 51 to 59 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.